Literature DB >> 23038813

Genomic (in)stability of the breast tumor microenvironment.

Seth Rummel1, Allyson L Valente, Jennifer L Kane, Craig D Shriver, Rachel E Ellsworth.   

Abstract

The breast tumor microenvironment plays an active role in tumorigenesis. Molecular alterations have been identified in tumor-associated stroma; however, there is considerable debate as to whether the stroma is characterized by genomic instability or whether detection of chromosomal alterations reflects technological artifact rather than the true genomic content of the tumor microenvironment. Thus, breast stroma specimens from 112 women undergoing reductive mammoplasty (n = 7), prophylactic mastectomy (n = 6), or mastectomy for a breast disease (n = 99) were frozen in optimal cutting temperature medium. Allelic imbalance (AI) analysis was conducted using a panel of 52 microsatellite markers in 484 stromal specimens from 98 women, of which 92% had no detectable AI events. When compared with previously generated AI data from 77 formalin-fixed, paraffin-embedded (FFPE) stroma specimens, 42% of which harbored at least one detectable AI event, the frequency of AI in the FFPE specimens (4.62%) was significantly higher (P < 0.001) than that found in frozen specimens (0.45%). This comparison of AI between FFPE and research-grade specimens suggests that past reports of AI in breast stroma reflect artifact in the archival specimens caused by formalin-fixation, paraffin-embedding and tissue storage. Furthermore, SNP data were generated from a subset of 86 stromal specimens using SNP arrays and copy number alterations were identified using Partek Genomics Suite. For 95% of the specimens, no detectable copy number alterations were found and the 11 changes that were detected were small and not shared between specimens. These data, therefore, support a model in which the tumor microenvironment is genetically stable.

Entities:  

Mesh:

Year:  2012        PMID: 23038813     DOI: 10.1158/1541-7786.MCR-12-0425

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  11 in total

1.  Cells Comprising the Prostate Cancer Microenvironment Lack Recurrent Clonal Somatic Genomic Aberrations.

Authors:  Daniella Bianchi-Frias; Ryan Basom; Jeffrey J Delrow; Ilsa M Coleman; Olga Dakhova; Xiaoyu Qu; Min Fang; Omar E Franco; Nolan G Ericson; Jason H Bielas; Simon W Hayward; Lawrence True; Colm Morrissey; Lisha Brown; Neil A Bhowmick; David Rowley; Michael Ittmann; Peter S Nelson
Journal:  Mol Cancer Res       Date:  2016-01-11       Impact factor: 5.852

2.  The impact of contrast-enhanced spectral mammogram (CESM) and three-dimensional breast ultrasound (3DUS) on the characterization of the disease extend in cancer patients.

Authors:  Maha Hussien Helal; Sahar Mahmoud Mansour; Lamia Adel Salaleldin; Basma Mohamed Alkalaawy; Dorria Saleh Salem; Nadia Mahmoud Mokhtar
Journal:  Br J Radiol       Date:  2018-05-24       Impact factor: 3.039

3.  Molecular Heterogeneity in Primary Breast Carcinomas and Axillary Lymph Node Metastases Assessed by Genomic Fingerprinting Analysis.

Authors:  Rachel E Ellsworth; Allyson L Toro; Heather L Blackburn; Alisha Decewicz; Brenda Deyarmin; Kimberly A Mamula; Nicholas S Costantino; Jeffrey A Hooke; Craig D Shriver; Darrell L Ellsworth
Journal:  Cancer Growth Metastasis       Date:  2015-07-20

4.  Genetic alterations and epigenetic alterations of cancer-associated fibroblasts.

Authors:  Heng Du; Guowei Che
Journal:  Oncol Lett       Date:  2016-11-30       Impact factor: 2.967

Review 5.  Teaming Up for Trouble: Cancer Cells, Transforming Growth Factor-β1 Signaling and the Epigenetic Corruption of Stromal Naïve Fibroblasts.

Authors:  Sergio Lamprecht; Ina Sigal-Batikoff; Shraga Shany; Naim Abu-Freha; Eduard Ling; George J Delinasios; Keren Moyal-Atias; John G Delinasios; Alexander Fich
Journal:  Cancers (Basel)       Date:  2018-02-27       Impact factor: 6.639

Review 6.  Stromal cells in breast cancer as a potential therapeutic target.

Authors:  Samantha S Dykes; Veronica S Hughes; Jennifer M Wiggins; Henrietta O Fasanya; Mai Tanaka; Dietmar Siemann
Journal:  Oncotarget       Date:  2018-05-04

7.  CSL controls telomere maintenance and genome stability in human dermal fibroblasts.

Authors:  Giulia Bottoni; Atul Katarkar; Beatrice Tassone; Soumitra Ghosh; Andrea Clocchiatti; Sandro Goruppi; Pino Bordignon; Paris Jafari; Fabio Tordini; Thomas Lunardi; Wolfram Hoetzenecker; Victor Neel; Joachim Lingner; G Paolo Dotto
Journal:  Nat Commun       Date:  2019-08-29       Impact factor: 14.919

Review 8.  Breast Cancer CAFs: Spectrum of Phenotypes and Promising Targeting Avenues.

Authors:  Eiman Elwakeel; Andreas Weigert
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

Review 9.  Antibody drug conjugate: the "biological missile" for targeted cancer therapy.

Authors:  Zhiwen Fu; Shijun Li; Sifei Han; Chen Shi; Yu Zhang
Journal:  Signal Transduct Target Ther       Date:  2022-03-22

10.  Short somatic alterations at the site of copy number variation in breast cancer.

Authors:  Fumi Murakami; Yumi Tsuboi; Yuka Takahashi; Yoshiya Horimoto; Kaoru Mogushi; Takeshi Ito; Mitsuru Emi; Daisuke Matsubara; Tatsuhiro Shibata; Mitsue Saito; Yoshinori Murakami
Journal:  Cancer Sci       Date:  2020-12-11       Impact factor: 6.518

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.